Cargando…

The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor

OBJECTIVES: The aim of this study was to examine the following by using a non‐wearable monitor: (ⅰ) the trajectory of vital signs (VS) in the last 2 weeks of life among cancer patients, and (ⅱ) the difference in change over time of VS between cancer patients with and without opioid use. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Haruka, Fukui, Sakiko, Maeda, Isseki, Hatano, Yutaka, Higuchi, Akari, Higami, Yoko, Yamakawa, Miyae, Utsumi, Momoe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683542/
https://www.ncbi.nlm.nih.gov/pubmed/34845870
http://dx.doi.org/10.1002/cam4.4382
_version_ 1784617443175432192
author Tanaka, Haruka
Fukui, Sakiko
Maeda, Isseki
Hatano, Yutaka
Higuchi, Akari
Higami, Yoko
Yamakawa, Miyae
Utsumi, Momoe
author_facet Tanaka, Haruka
Fukui, Sakiko
Maeda, Isseki
Hatano, Yutaka
Higuchi, Akari
Higami, Yoko
Yamakawa, Miyae
Utsumi, Momoe
author_sort Tanaka, Haruka
collection PubMed
description OBJECTIVES: The aim of this study was to examine the following by using a non‐wearable monitor: (ⅰ) the trajectory of vital signs (VS) in the last 2 weeks of life among cancer patients, and (ⅱ) the difference in change over time of VS between cancer patients with and without opioid use. METHODS: We conducted a longitudinal study involving cancer patients in a palliative care unit (PCU) from April 2018 to October 2019. VS were collected continuously using a non‐wearable monitor, and we calculated the means of respiratory rate (RR) and heart rate (HR) per hour, and counts of apnea per hour as outcome variables. Explanatory variables were time (subtracting time of death from measurement time of VS, divided by 36) and opioid use. Mean difference (MD) of time represented the slope per hour of VS values. First, we analyzed the associations between VS per hour and time using a linear mixed model (LMM) with random intercepts and slope over time. Second, we analyzed the associations between VS and interaction term between time and opioid use. RESULTS: We analyzed 26 cancer patients. RR (MD: 0.27 beats/min [95% CI: 0.27–0.28]), HR (MD: 1.51 beats/min [95% CI: 1.50–1.52]), and apnea (MD: 0.71 count/hour [95% CI: 0.70–0.72]) significantly increased hourly. In addition, RR was significantly associated with interaction term (MD: −1.59 beats/min [95% CI: −3.11 to −0.07]), which indicates that there is a difference in the slope of RR between opioid users and non‐users. CONCLUSIONS: We have successfully described the trajectory of VS in high‐resolution under conditions of a natural end of life in PCU.
format Online
Article
Text
id pubmed-8683542
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86835422021-12-30 The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor Tanaka, Haruka Fukui, Sakiko Maeda, Isseki Hatano, Yutaka Higuchi, Akari Higami, Yoko Yamakawa, Miyae Utsumi, Momoe Cancer Med Clinical Cancer Research OBJECTIVES: The aim of this study was to examine the following by using a non‐wearable monitor: (ⅰ) the trajectory of vital signs (VS) in the last 2 weeks of life among cancer patients, and (ⅱ) the difference in change over time of VS between cancer patients with and without opioid use. METHODS: We conducted a longitudinal study involving cancer patients in a palliative care unit (PCU) from April 2018 to October 2019. VS were collected continuously using a non‐wearable monitor, and we calculated the means of respiratory rate (RR) and heart rate (HR) per hour, and counts of apnea per hour as outcome variables. Explanatory variables were time (subtracting time of death from measurement time of VS, divided by 36) and opioid use. Mean difference (MD) of time represented the slope per hour of VS values. First, we analyzed the associations between VS per hour and time using a linear mixed model (LMM) with random intercepts and slope over time. Second, we analyzed the associations between VS and interaction term between time and opioid use. RESULTS: We analyzed 26 cancer patients. RR (MD: 0.27 beats/min [95% CI: 0.27–0.28]), HR (MD: 1.51 beats/min [95% CI: 1.50–1.52]), and apnea (MD: 0.71 count/hour [95% CI: 0.70–0.72]) significantly increased hourly. In addition, RR was significantly associated with interaction term (MD: −1.59 beats/min [95% CI: −3.11 to −0.07]), which indicates that there is a difference in the slope of RR between opioid users and non‐users. CONCLUSIONS: We have successfully described the trajectory of VS in high‐resolution under conditions of a natural end of life in PCU. John Wiley and Sons Inc. 2021-11-29 /pmc/articles/PMC8683542/ /pubmed/34845870 http://dx.doi.org/10.1002/cam4.4382 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Tanaka, Haruka
Fukui, Sakiko
Maeda, Isseki
Hatano, Yutaka
Higuchi, Akari
Higami, Yoko
Yamakawa, Miyae
Utsumi, Momoe
The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor
title The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor
title_full The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor
title_fullStr The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor
title_full_unstemmed The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor
title_short The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor
title_sort change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: continuous measurement of vital signs using a non‐wearable monitor
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683542/
https://www.ncbi.nlm.nih.gov/pubmed/34845870
http://dx.doi.org/10.1002/cam4.4382
work_keys_str_mv AT tanakaharuka thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT fukuisakiko thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT maedaisseki thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT hatanoyutaka thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT higuchiakari thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT higamiyoko thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT yamakawamiyae thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT utsumimomoe thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT tanakaharuka changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT fukuisakiko changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT maedaisseki changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT hatanoyutaka changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT higuchiakari changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT higamiyoko changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT yamakawamiyae changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor
AT utsumimomoe changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor